Work

Supplementary Figure S5 from Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial

Year: 2025
Type: supplementary-materials
Abstract: T-cell subsets and tumor-reactive T-cells in advanced HER2+ GC
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4410340166
Cites:
Cited by:
Related to: 10